サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1756477

診断における人工知能市場：コンポーネント別、診断別、国別、地域別- 産業分析、市場規模、市場シェア、2024年～2032年の予測

Artificial Intelligence in Diagnostics Market, By Component, By Diagnosis, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 398 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.58円
診断における人工知能市場：コンポーネント別、診断別、国別、地域別- 産業分析、市場規模、市場シェア、2024年～2032年の予測
出版日: 2025年05月23日
発行: AnalystView Market Insights
ページ情報: 英文 398 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

診断における人工知能市場規模は2024年に15億6,712万米ドルとなり、2024～2032年にかけてCAGR 22.5％で拡大

診断における人工知能市場-市場力学

早期かつ正確な疾患検出に対する需要の高まり

早期かつ正確な診断を重視する傾向が強まっていることが、診断用AI市場の主要促進要因となっています。世界中のヘルスケアシステムは、患者の転帰を改善し、治療費を削減するために、病気のタイムリーな特定を優先しています。人工知能は、医療画像、遺伝子プロファイル、電子カルテなどの複雑なデータセットを迅速に分析することで診断精度を高めています。この能力は、がん、心血管疾患、神経障害などの疾患の早期発見をサポートします。その結果、病院、クリニック、診断ラボは、エラーを最小限に抑え、診断を迅速化し、個別化された治療決定をサポートするために、AIツールの採用を増やしています。

診断における人工知能市場-主要な洞察

弊社の調査アナリストによると、世界の診断における人工知能市場は、2024～2032年の間に約22.5％のCAGRで開発されると予測されています。

2024年のコンポーネント別セグメントでは、ソフトウェアカテゴリが市場を独占しています。

診断別では、放射線学セグメントが2024年に最も収益を上げました。

地域別では、2024年に北米が最も収益の高い地域でした。

診断における人工知能市場-セグメンテーション分析

世界の人工知能診断市場は3つのカテゴリーに分類されます：コンポーネント、診断、地域です。

診断における人工知能市場は、コンポーネント別にソフトウェア、ハードウェア、サービスに区分されます。このうちソフトウェアは、データの処理、アルゴリズムの実行、診断出力の生成において中心的な役割を果たすため、支配的なセグメントとして浮上しています。AIを搭載したソフトウェアソリューションは、医療画像の解釈、検査結果の分析、臨床上の意思決定のサポートに不可欠です。これらのプラットフォームは、機械学習を通じて継続的に進化し、時間の経過とともに精度を向上させ、複雑な診断課題に適応しています。AIソフトウェアと病院システム、電子カルテ（EHR）、画像診断機器との統合が進むことで、市場でのリーダーシップはさらに強化されます。さらに、ソフトウェアソリューションは拡大性、リモートアクセス、コスト効率を提供するため、先行投資やインフラサポートが高額になりがちなハードウェアやサービスコンポーネントと比較して、医療提供者にとって魅力的なものとなっています。

診断における人工知能市場は、診断別に心臓病学、腫瘍学、病理学、放射線学、胸部・肺、神経学、その他に区分されます。このうち放射線科は、膨大な画像データが生成され、正確な解釈が不可欠であることから、圧倒的なシェアを占めています。AIは、X線、MRI、CTスキャン、超音波の分析を強化し、腫瘍、骨折、内出血などの異常をより迅速かつ正確に検出できるようにすることで、放射線医療に革命をもたらしています。微妙なパターンを検出し、診断ミスを減らすAIアルゴリズムの能力は、放射線科医にとってかけがえのないツールとなっています。さらに、特に慢性疾患管理や救急医療における画像診断に対する需要の高まりが、放射線科におけるAIの採用を促進し続け、市場でのリーダーシップを強化しています。

診断における人工知能市場-地理的洞察

診断における人工知能市場は、地理的には北米、アジア太平洋、ラテンアメリカ、欧州、中東・アフリカに分布しています。これらの地域は、ビジネスをもたらしている国に基づいてさらに分割されます。

北米は主に米国が牽引し、診断用人工知能市場を独占しています。同地域は、確立されたヘルスケアインフラ、AI技術への大規模な投資、政府の支援イニシアティブの恩恵を受けています。大手ハイテク企業や新興企業は病院と協力し、特に放射線学や腫瘍学のセグメントで先進的診断ツールを開発しています。電子カルテ（EHR）の高い導入率、慢性疾患の有病率の上昇、精密医療への需要の高まりが、市場の成長をさらに後押ししています。FDAのような規制機関は、AIベースの診断ツールを積極的に承認しており、臨床応用への信頼を高めています。これらの要因から、北米はAI主導の診断イノベーションにおける世界的リーダーとして位置づけられています。

アジア太平洋は、中国、日本、インドなどの国々に牽引され、診断用AI市場の主要成長地域として浮上しています。ヘルスケアにおける急速なデジタルトランスフォーメーション、AI新興企業への投資の増加、ヘルステック革新に対する政府の関心の高まりが市場拡大を後押ししています。同地域は、患者数の多さと慢性疾患の罹患率の上昇に直面しており、スケーラブルで効率的な診断ソリューションに対する強い需要を生み出しています。さらに、中国のAI開発計画やインドのデジタルヘルスケア推進のようなイニシアチブがエコシステムを強化しています。現地の病院と世界のハイテク企業とのコラボレーションがAIの導入を加速しており、アジア太平洋はダイナミックで急速に拡大する市場となっています。

診断における人工知能市場-競合情勢

診断における人工知能市場の競合力学は、イノベーションを推進する機敏な新興企業とともに、既存のヘルスケアと医療技術大手によって形成されています。Siemens Healthineers、GE Healthcare、Aidoc、Digital Diagnostics, Inc.などの企業は、医療画像、心臓病学、病理学に特化した強固なAIプラットフォームを通じて優位に立っています。これらの大手企業は、研究開発投資、規制対応、戦略的パートナーシップを優先し、AIポートフォリオを拡大しています。一方、Vuno, Inc.やNovaSignal Corporationのような新興参入企業は、特に神経学とリアルタイムデータ分析において破壊的なソリューションをもたらしています。この健全な競争環境は、継続的な製品の進歩、診断におけるより広範なAIの統合、ヘルスケア専門家のための臨床意思決定支援の強化を促進します。

目次

第1章 診断市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 診断における人工知能の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 診断産業における人工知能の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長展望マッピング
  • 規制枠組み分析

第5章 診断における人工知能市場： COVID-19の影響分析

  • COVID-19前の影響分析
  • COVID-19後の影響分析

第6章 診断市場情勢

  • 診断における人工知能市場のシェア分析、2023年
  • 主要メーカー別内訳データ
    • ベテラン選手の分析
    • 新興企業の分析

第7章 診断における人工知能市場-コンポーネント別

  • 概要
    • コンポーネント別セグメントシェア分析
    • ソフトウェア
    • ハードウェア
    • サービス

第8章 診断における人工知能市場-診断別

  • 概要
    • 診断別セグメントシェア分析
    • 心臓病学
    • 腫瘍学
    • 病理学
    • 放射線学
    • 胸部・肺
    • 神経学
    • その他

第9章 診断における人工知能市場-地域

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • 英国
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 韓国
    • 日本
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第10章 主要ベンダー分析-診断産業における人工知能

  • 競合ダッシュボード
  • 企業プロファイル
    • Siemens Healthineers
    • Zebra Technologies Corp.
    • Riverain Technologies
    • Vuno, Inc.
    • Aidoc
    • NovaSignal Corporation
    • Imagen
    • Digital Diagnostics, Inc.
    • GE Healthcare
    • AliveCor Inc.
    • F. Hoffmann-La Roche Ltd
    • その他

第11章 アナリストの全方位展望

目次
Product Code: ANV5269

REPORT HIGHLIGHT

Artificial Intelligence in Diagnostics Market size was valued at USD 1,567.12 Million in 2024, expanding at a CAGR of 22.5% from 2024 to 2032.

Artificial Intelligence in Diagnostics refers to the use of advanced algorithms and machine learning techniques to analyze medical data and assist in identifying diseases or conditions. By processing vast amounts of clinical information, imaging, and patient history, AI systems can detect patterns and anomalies often invisible to the human eye. This technology enhances accuracy, speeds up diagnosis, and supports healthcare professionals in making informed decisions. AI-driven diagnostics improve early disease detection, personalize treatment plans, and optimize healthcare outcomes while reducing errors and costs. It represents a transformative tool in modern medicine, integrating data science with clinical expertise.

Artificial Intelligence in Diagnostics Market- Market Dynamics

Rising Demand for Early and Accurate Disease Detection

The growing emphasis on early and precise diagnosis is a major driver for the AI in diagnostics market. Healthcare systems worldwide are prioritizing timely identification of diseases to improve patient outcomes and reduce treatment costs. Artificial Intelligence enhances diagnostic accuracy by swiftly analyzing complex datasets such as medical images, genetic profiles, and electronic health records. This capability supports early detection of conditions like cancer, cardiovascular diseases, and neurological disorders. As a result, hospitals, clinics, and diagnostic labs are increasingly adopting AI tools to minimize errors, accelerate diagnosis, and support personalized treatment decisions.

Artificial Intelligence in Diagnostics Market- Key Insights

According to our research analyst, the global Artificial Intelligence in Diagnostics Market is expected to develop at a CAGR of approximately 22.5% between 2024-2032.

Segmented by Component in 2024, the Software category dominated the market.

Based on Diagnosis, the Radiology segment generated the most income in 2024.

On the basis of region, in 2024, North America was the region with the highest revenue.

Artificial Intelligence in Diagnostics Market- Segmentation Analysis:

The global Artificial Intelligence in Diagnostics Market is divided into Three categories: Component, Diagnosis, and Region.

The Artificial Intelligence in Diagnostics market is segmented by component into software, hardware, and services. Among these, software emerges as the dominant segment due to its central role in processing data, executing algorithms, and generating diagnostic outputs. AI-powered software solutions are integral for interpreting medical images, analyzing lab results, and supporting clinical decision-making. These platforms continuously evolve through machine learning, improving accuracy over time and adapting to complex diagnostic challenges. The growing integration of AI software with hospital systems, electronic health records (EHRs), and imaging equipment further strengthens its market leadership. Additionally, software solutions offer scalability, remote access, and cost-efficiency, making them more attractive to healthcare providers compared to hardware and service components, which often require higher upfront investments and infrastructure support.

The Artificial Intelligence in Diagnostics market, by diagnosis, is segmented into cardiology, oncology, pathology, radiology, chest and lung, neurology, and others. Among these, radiology holds the dominant share due to the vast volume of imaging data it generates and the critical need for accurate interpretation. AI is revolutionizing radiology by enhancing the analysis of X-rays, MRIs, CT scans, and ultrasounds, enabling faster and more accurate detection of abnormalities such as tumors, fractures, and internal bleeding. The ability of AI algorithms to detect subtle patterns and reduce diagnostic errors makes them invaluable tools for radiologists. Furthermore, rising demand for imaging diagnostics, especially in chronic disease management and emergency care, continues to drive AI adoption in radiology, reinforcing its market leadership.

Artificial Intelligence in Diagnostics Market- Geographical Insights

Geographically, the Artificial Intelligence in Diagnostics Market is distributed throughout North America, Asia Pacific, Latin America, Europe, the Middle East, and Africa. These regions are further divided based on the nations bringing in business.

North America dominates the Artificial Intelligence in Diagnostics market, primarily driven by the United States. The region benefits from a well-established healthcare infrastructure, significant investments in AI technologies, and supportive government initiatives. Leading tech firms and startups collaborate with hospitals to develop advanced diagnostic tools, especially in radiology and oncology. High adoption rates of electronic health records (EHRs), rising chronic disease prevalence, and increasing demand for precision medicine further fuel market growth. Regulatory bodies like the FDA actively approve AI-based diagnostic tools, boosting confidence in clinical applications. These factors position North America as a global leader in AI-driven diagnostic innovations.

Asia Pacific is emerging as a key growth region in the AI in Diagnostics market, led by countries such as China, Japan, and India. Rapid digital transformation in healthcare, growing investments in AI startups, and increasing government focus on health tech innovation are propelling market expansion. The region faces high patient volumes and rising incidences of chronic diseases, creating a strong demand for scalable, efficient diagnostic solutions. Additionally, initiatives like China's AI development plans and India's push for digital healthcare strengthen the ecosystem. Collaborations between local hospitals and global tech companies are accelerating AI adoption, making Asia Pacific a dynamic and rapidly expanding market.

Artificial Intelligence in Diagnostics Market- Competitive Landscape:

The competitive dynamics of the Artificial Intelligence in Diagnostics market are shaped by established healthcare and med-tech giants alongside agile startups driving innovation. Companies such as Siemens Healthineers, GE Healthcare, Aidoc, and Digital Diagnostics, Inc. dominate through robust AI platforms focused on medical imaging, cardiology, and pathology. These leaders prioritize R&D investments, regulatory compliance, and strategic partnerships to expand their AI portfolios. Meanwhile, emerging players like Vuno, Inc. and NovaSignal Corporation bring disruptive solutions, particularly in neurology and real-time data analysis. This healthy competitive mix promotes continuous product advancement, broader AI integration in diagnostics, and enhanced clinical decision support for healthcare professionals.

Recent Developments:

In March 2024, Aidoc partnered with the American College of Radiology to launch a nationwide clinical AI deployment initiative, enhancing stroke and pulmonary embolism detection.

In January 2025, Vuno, Inc. received European CE certification for its AI-powered VUNO Med-Chest X-ray(TM) solution, accelerating its expansion across EU healthcare systems.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ARTIFICIAL INTELLIGENCE IN DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Siemens Healthineers
  • Zebra Technologies Corp.
  • Riverain Technologies
  • Vuno, Inc.
  • Aidoc
  • NovaSignal Corporation
  • Imagen
  • Digital Diagnostics, Inc.
  • GE Healthcare
  • AliveCor Inc.
  • F. Hoffmann-La Roche Ltd
  • Others

GLOBAL ARTIFICIAL INTELLIGENCE IN DIAGNOSTICS MARKET, BY COMPONENT - MARKET ANALYSIS, 2019 - 2032

  • Software
  • Hardware
  • Services

GLOBAL ARTIFICIAL INTELLIGENCE IN DIAGNOSTICS MARKET, BY DIAGNOSIS - MARKET ANALYSIS, 2019 - 2032

  • Cardiology
  • Oncology
  • Pathology
  • Radiology
  • Chest and Lung
  • Neurology
  • Others

GLOBAL ARTIFICIAL INTELLIGENCE IN DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Artificial Intelligence in Diagnostics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Artificial Intelligence in Diagnostics Market Snippet by Component
    • 2.1.2. Artificial Intelligence in Diagnostics Market Snippet by Diagnosis
    • 2.1.3. Artificial Intelligence in Diagnostics Market Snippet by Country
    • 2.1.4. Artificial Intelligence in Diagnostics Market Snippet by Region
  • 2.2. Competitive Insights

3. Artificial Intelligence in Diagnostics Key Market Trends

  • 3.1. Artificial Intelligence in Diagnostics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Artificial Intelligence in Diagnostics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Artificial Intelligence in Diagnostics Market Opportunities
  • 3.4. Artificial Intelligence in Diagnostics Market Future Trends

4. Artificial Intelligence in Diagnostics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Artificial Intelligence in Diagnostics Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Artificial Intelligence in Diagnostics Market Landscape

  • 6.1. Artificial Intelligence in Diagnostics Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Artificial Intelligence in Diagnostics Market - By Component

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Component, 2023 & 2032 (%)
    • 7.1.2. Software
    • 7.1.3. Hardware
    • 7.1.4. Services

8. Artificial Intelligence in Diagnostics Market - By Diagnosis

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Diagnosis, 2023 & 2032 (%)
    • 8.1.2. Cardiology
    • 8.1.3. Oncology
    • 8.1.4. Pathology
    • 8.1.5. Radiology
    • 8.1.6. Chest and Lung
    • 8.1.7. Neurology
    • 8.1.8. Others

9. Artificial Intelligence in Diagnostics Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Artificial Intelligence in Diagnostics Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Artificial Intelligence in Diagnostics Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 9.3.7. France
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.7.3. France Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.3.7.4. France Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 9.3.8. Italy
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.8.3. Italy Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.3.8.4. Italy Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 9.3.9. Spain
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.9.3. United Kingdom Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.3.9.4. United Kingdom Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 9.3.10. United Kingdom
      • 9.3.10.1. Overview
      • 9.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.10.3. United Kingdom Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.3.10.4. United Kingdom Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 9.3.11. Russia
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.11.2. Russia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.3.11.3. Russia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 9.3.12. Netherlands
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.12.2. Netherlands Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.3.12.3. Netherlands Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 9.3.13. Sweden
      • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.13.2. Sweden Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.3.13.3. Sweden Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 9.3.14. Poland
      • 9.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.14.2. Poland Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.3.14.3. Poland Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 9.3.15. Rest of Europe
      • 9.3.15.1. Overview
      • 9.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.15.3. Rest of the Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.3.15.4. Rest of the Europe Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Artificial Intelligence in Diagnostics Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 9.4.8. South Korea
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.8.3. South Korea Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.4.8.4. South Korea Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 9.4.9. Japan
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.9.3. Japan Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.4.9.4. Japan Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 9.4.11. Thailand
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.11.3. Thailand Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.4.11.4. Thailand Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 9.4.12. Indonesia
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.12.3. Indonesia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.4.12.4. Indonesia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Artificial Intelligence in Diagnostics Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Artificial Intelligence in Diagnostics Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)

10. Key Vendor Analysis- Artificial Intelligence in Diagnostics Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. Siemens Healthineers
    • 10.2.2. Zebra Technologies Corp.
    • 10.2.3. Riverain Technologies
    • 10.2.4. Vuno, Inc.
    • 10.2.5. Aidoc
    • 10.2.6. NovaSignal Corporation
    • 10.2.7. Imagen
    • 10.2.8. Digital Diagnostics, Inc.
    • 10.2.9. GE Healthcare
    • 10.2.10. AliveCor Inc.
    • 10.2.11. F. Hoffmann-La Roche Ltd
    • 10.2.12. Others

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us